Cytek Biosciences, Inc. (CTKB) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $90.85M | -8.0% |
| 2024 | $98.72M | -41.0% |
| 2023 | $167.30M | -43.6% |
| 2022 | $296.60M | -18.7% |
| 2021 | $364.62M | +120.7% |
| 2020 | $165.23M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $90.85M | -8.0% |
| 2024 | $98.72M | -41.0% |
| 2023 | $167.30M | -43.6% |
| 2022 | $296.60M | -18.7% |
| 2021 | $364.62M | +120.7% |
| 2020 | $165.23M | — |